Design: The CAST is a pragmatic, open-label, multicenter, two-period cluster-randomized superiority trial. Enrollment took place from 30 May 2020 until 11 November 2021, and patients were followed for one year.
Setting: Inclusion took place at the emergency department in ten hospitals located in the Netherlands.
Participants: Eligible participants had a displaced DRF that was acceptably aligned after closed reduction.
Interventions: A below-elbow complete circumferential cast (CC) or a below-elbow plaster of Paris volar-dorsal splint (PS).
SPSS, 15.0
Data will be available for researchers who provide a methodologically sound scientific proposal, which has been approved by an ethical committee. Proof of the latter should be provided. Analyses should achieve the aims as reported in the approved proposal. Proposals for data should be directed to m.reijman@erasmusmc.nl.
The data are sensitive since they involve personal information of patients. There are restrictions on use by commercial parties and on sharing openly, based on (inter)national laws and regulations and written informed consent. Therefore these data (and additional clinical data) are only available upon signing a Data Transfer Agreement (see Terms of Access).